ResMed Inc (RMD)
Debt-to-equity ratio
| Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 4,864,040 | 4,629,920 | 4,481,850 | 4,250,380 | 4,129,900 | 3,932,510 | 3,738,130 | 3,432,890 | 3,360,750 | 3,278,800 | 3,145,840 | 3,026,050 | 2,885,680 | 2,709,230 | 2,864,980 | 2,678,860 | 2,497,030 | 2,256,430 | 2,258,110 | 2,117,250 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
June 30, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $4,864,040K
= 0.00
The debt-to-equity ratio of ResMed Inc has consistently been 0.00 across multiple reporting periods, indicating that the company has been utilizing primarily equity financing rather than relying on debt to fund its operations and investments. This low or zero debt-to-equity ratio suggests that ResMed Inc has a strong financial position with a minimal level of debt relative to its equity. The company's ability to maintain a low debt-to-equity ratio may indicate a conservative financial strategy aimed at reducing financial risk and increasing financial stability. Investors and creditors may view the company positively due to its low debt levels, potentially signaling a lower risk of financial distress or default.
Peer comparison
Jun 30, 2024